Evogene Ltd. Form 6-K Summary
Business Context and Reporting Period
This Form 6-K was filed by Evogene Ltd., a foreign private issuer, for the month of April 2019. The report was signed on April 15, 2019, by Dorit Kreiner, Chief Financial Officer. The filing serves to incorporate by reference a slide presentation titled "Canonic Company Introduction – April 2019."
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a cover sheet for an attached exhibit and does not contain a financial table or narrative within the provided text.
Material Changes
The filing text does not provide information regarding material changes versus prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumably contained within the attached Exhibit 99.1, which is not included in the source text.
Key Facts for Investor Verification
- Verify the contents of Exhibit 99.1 ("Canonic Company Introduction – April 2019") for actual financial data and strategic updates.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that this specific filing text contains no quantitative financial data.